Abstract

Sarcoidosis is a complex systemic granulomatous disease of unknown etiology characterized by the presence of activated macrophages and Th1/Th17 effector cells. Data mining of our RNA-Seq analysis of CD14+ monocytes showed enrichment for metabolic and hypoxia inducible factor (HIF) pathways in sarcoidosis. Further investigation revealed that sarcoidosis macrophages and monocytes exhibit higher protein levels for HIF-α isoforms, HIF-1β, and their transcriptional co-activator p300 as well as glucose transporter 1 (Glut1). In situ hybridization of sarcoidosis granulomatous lung tissues showed abundance of HIF-1α in the center of granulomas. The abundance of HIF isoforms was mechanistically linked to elevated IL-1β and IL-17 since targeted down regulation of HIF-1α via short interfering RNA or a HIF-1α inhibitor decreased their production. Pharmacological intervention using chloroquine, a lysosomal inhibitor, decreased lysosomal associated protein 2 (LAMP2) and HIF-1α levels and modified cytokine production. These data suggest that increased activity of HIF-α isoforms regulate Th1/Th17 mediated inflammation in sarcoidosis.

Data availability

All data generated or analysed during this study are included in the manuscript.

Article and author information

Author details

  1. Jaya Talreja

    Department of Internal Medicine, Wayne State University, Detroit, United States
    For correspondence
    fq0442@wayne.edu
    Competing interests
    The authors declare that no competing interests exist.
  2. Harvinder Talwar

    Department of Internal Medicine, Wayne State University, Detroit, United States
    For correspondence
    htalwar@med.wayne.edu
    Competing interests
    The authors declare that no competing interests exist.
  3. Christian Bauerfeld

    Department of Pediatrics, Wayne State University, Detroit, United States
    For correspondence
    cbauerfe@med.wayne.edu
    Competing interests
    The authors declare that no competing interests exist.
  4. Lawrence I Grossman

    Center for Molecular Medicine and Genetics, Wayne State University, Detroit, United States
    For correspondence
    lgrossman@wayne.edu
    Competing interests
    The authors declare that no competing interests exist.
  5. Kezhong Zhang

    Center for Molecular Medicine and Genetics, Wayne State University, Detroit, United States
    For correspondence
    kzhang@med.wayne.edu
    Competing interests
    The authors declare that no competing interests exist.
  6. Paul Tranchida

    Department of Pathology, Wayne State University, Detroit, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Lobelia Samavati

    Department of Internal Medicine, Wayne State University, Detroit, United States
    For correspondence
    ay6003@wayne.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3327-2585

Funding

National Heart, Lung, and Blood Institute (R01HL113508)

  • Lobelia Samavati

American Lung Association

  • Lobelia Samavati

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: The Committee for Investigations Involving Human Subjects at Wayne State University approved the protocol for obtaining alveolar macrophages by bronchoalveolar lavage (BAL) and blood by phlebotomy from control subjects and patients with sarcoidosis.The IRB number for this study is 055208MP4E. Informed consent was obtained from all subjects enrolled for the study.

Copyright

© 2019, Talreja et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,393
    views
  • 337
    downloads
  • 46
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Jaya Talreja
  2. Harvinder Talwar
  3. Christian Bauerfeld
  4. Lawrence I Grossman
  5. Kezhong Zhang
  6. Paul Tranchida
  7. Lobelia Samavati
(2019)
HIF-1α regulates IL-1β and IL-17 in sarcoidosis
eLife 8:e44519.
https://doi.org/10.7554/eLife.44519

Share this article

https://doi.org/10.7554/eLife.44519

Further reading

    1. Medicine
    Jon R Lorsch, Lawrence A Tabak, Monica M Bertagnolli
    Feature Article

    Three senior figures at the US National Institutes of Health explain why the agency remains committed to supporting basic science and research.

    1. Medicine
    Teruhiko Yoshida, Khun Zaw Latt ... Jeffrey B Kopp
    Research Article

    HIV disease remains prevalent in the USA and chronic kidney disease remains a major cause of morbidity in HIV-1-positive patients. Host double-stranded RNA (dsRNA)-activated protein kinase (PKR) is a sensor for viral dsRNA, including HIV-1. We show that PKR inhibition by compound C16 ameliorates the HIV-associated nephropathy (HIVAN) kidney phenotype in the Tg26 transgenic mouse model, with reversal of mitochondrial dysfunction. Combined analysis of single-nucleus RNA-seq and bulk RNA-seq data revealed that oxidative phosphorylation was one of the most downregulated pathways and identified signal transducer and activator of transcription (STAT3) as a potential mediating factor. We identified in Tg26 mice a novel proximal tubular cell cluster enriched in mitochondrial transcripts. Podocytes showed high levels of HIV-1 gene expression and dysregulation of cytoskeleton-related genes, and these cells dedifferentiated. In injured proximal tubules, cell-cell interaction analysis indicated activation of the pro-fibrogenic PKR-STAT3-platelet-derived growth factor (PDGF)-D pathway. These findings suggest that PKR inhibition and mitochondrial rescue are potential novel therapeutic approaches for HIVAN.